Low Dose Ketamine for Chronic Pain Syndromes

Editorial review

Educational content is reviewed for source quality, clinical boundaries, and readability. It is not medical advice; confirm care decisions with a licensed clinician.

Low dose ketamine may provide short-term pain relief for some people with chronic pain syndromes, particularly complex regional pain syndrome (CRPS) and certain neuropathic pain conditions. It is usually considered when standard treatments have not provided adequate relief, and it should be delivered within a clinician-led pain plan that includes monitoring and rehabilitation. Evidence is stronger for some conditions than others, and the duration of benefit varies widely.

Ketamine is an anesthetic medication that blocks N-methyl-D-aspartate, or NMDA, receptors involved in pain signaling and central sensitization. Central sensitization is a state in which the nervous system becomes more reactive to pain signals, which can contribute to allodynia, hyperalgesia, and persistent pain.

Quick Answer

Low dose ketamine is used in some specialist pain settings for refractory CRPS and neuropathic pain, usually as a monitored intravenous infusion. It may reduce pain for days or weeks in some patients, but it is not a cure and does not help every type of chronic pain. A clinician should assess the pain diagnosis, medical history, medicines, and treatment goals before considering it.

What low dose ketamine can and cannot treat

Low dose ketamine is most relevant when pain has neuropathic or centrally sensitized features. Neuropathic pain results from a lesion or disease affecting the somatosensory nervous system. Examples include painful diabetic neuropathy, post-herpetic neuralgia, and pain after spinal cord injury.

Ketamine is less likely to address a purely mechanical source of pain, such as pain driven mainly by structural strain, or an untreated inflammatory condition. That distinction matters because a promising mechanism is not the same as a diagnosis or a treatment recommendation.

For readers weighing options, the practical question is whether a qualified pain clinician believes central sensitization or neuropathic mechanisms are part of the condition, and whether lower-risk treatments have been adequately tried. See our guide to ketamine drug interactions before discussing treatment with a prescriber.

What the research says about chronic pain

The evidence for ketamine in chronic pain is mixed and condition-specific. A 2018 consensus guideline from the American Society of Regional Anesthesia and Pain Medicine and partner organizations concluded that evidence supports intravenous ketamine for CRPS, while evidence for other chronic pain conditions is weaker or more limited. The guideline also emphasizes patient selection, monitoring, and clinician training.

According to the 2018 consensus guidelines on intravenous ketamine for chronic pain, the strongest evidence reviewed was for CRPS, with lower certainty for several other chronic pain conditions.

Complex regional pain syndrome

CRPS is a chronic pain condition that can involve severe limb pain, swelling, changes in skin temperature or color, movement problems, and sensitivity to touch. In a randomized controlled trial, Sigtermans and colleagues reported lower pain scores during and after a multi-day ketamine infusion compared with placebo, although functional improvement did not clearly follow the pain reduction. The study is available through PubMed.

This is an important limitation. Lower pain intensity can create an opportunity to participate in physical therapy or other rehabilitation, but an infusion alone does not establish lasting functional recovery.

Fibromyalgia

Fibromyalgia involves widespread pain along with symptoms that may include fatigue, sleep disruption, and cognitive difficulties. Small studies have shown that ketamine can affect experimentally measured pain sensitivity, but durable clinical benefit from routine ketamine treatment remains uncertain. Readers with fibromyalgia should be cautious about treating a short-term response as proof that repeat treatment will provide sustained improvement.

Neuropathic pain and back pain

Some people with neuropathic pain may experience temporary relief after ketamine, but study designs, doses, and follow-up periods differ substantially. Back pain is not one diagnosis. Ketamine may be considered when a clinician identifies a neuropathic or centrally sensitized component, but it is not a general treatment for every form of chronic back pain.

The CDC Clinical Practice Guideline for Prescribing Opioids for Pain recommends a patient-centered approach that considers nonopioid therapies and nonpharmacologic treatments for chronic pain. That broader approach remains relevant whether or not ketamine is being considered.

How ketamine is used in pain care

Chronic-pain ketamine protocols vary by diagnosis, treatment setting, and patient tolerance. Specialist programs may use low-dose intravenous infusions over hours or across multiple days. Published protocols are not interchangeable, so a dosing schedule from a study or another patient should not be used as personal medical guidance.

Monitoring commonly includes blood pressure, oxygenation, heart rate, mental status, and adverse effects during treatment. Ketamine can temporarily raise blood pressure and heart rate and can cause nausea, dizziness, dissociation, perceptual changes, or sedation. Our overview of cardiovascular monitoring with ketamine explains why medical history and observation matter.

Ketamine for chronic pain should be part of a multimodal plan. Depending on the diagnosis, that plan may include physical therapy, sleep support, psychological care, medication review, and condition-specific interventions. The goal is not simply a lower pain score. It is safer function and a clearer path for the next stage of care.

Compare low-dose options

Review routes, dosing discussions, and alternatives before speaking with a clinician.

Compare options

Questions to discuss with a pain clinician

What is the most likely pain diagnosis, and is there evidence of neuropathic pain or central sensitization?

Which treatments have already been tried, at what dose or duration, and what was the result?

What benefit would count as meaningful, such as better sleep, walking, therapy participation, or reduced pain interference?

Which current medicines, alcohol use, cardiovascular conditions, or mental health symptoms need review first?

What monitoring, follow-up, and rehabilitation plan will accompany treatment?

When it may be reasonable to discuss

A specialist has identified CRPS, neuropathic pain, or central sensitization features.
Conventional treatment has not provided adequate relief.
There is a clear functional goal, such as participating more fully in rehabilitation.
The patient can receive appropriate screening and monitoring.

Important limitations

Response and duration of relief are unpredictable.
Research support differs substantially by condition.
Adverse effects and medical contraindications require individualized review.
Repeat treatment may be considered in some settings, but long-term benefit is not established for every condition.

Key Takeaway

Low dose ketamine is best viewed as a possible adjunct for selected chronic pain conditions, not a standalone answer. A diagnosis-driven plan and measurable functional goals make the conversation more useful.

Safety and next steps

Ketamine is not appropriate for everyone. A treating clinician may need to review uncontrolled high blood pressure, cardiovascular disease, psychosis or other serious psychiatric symptoms, pregnancy considerations, liver concerns, substance-use history, and interactions with current medicines. Do not combine ketamine with alcohol or adjust prescribed medicines without clinical advice. Read more about ketamine and alcohol safety risks.

If you are considering low dose ketamine for chronic pain, bring a concise history of your diagnosis, prior treatments, current medications, and the daily activities pain prevents. That helps a clinician determine whether ketamine is a reasonable topic for discussion or whether another part of the pain plan needs attention first.

Learn More

Contact Low Dose Ketamine to explore educational resources and discuss the next appropriate step for your care questions.

Frequently Asked Questions

Ketamine is an FDA-approved anesthetic, but its use for chronic pain is generally discussed as an off-label clinical use. A clinician can explain what that means for a specific diagnosis and setting.

Some studies and patient reports describe relief lasting days or weeks, while others find little or no sustained benefit. Duration depends on the condition, protocol, response, and the rest of the treatment plan.

No. When ketamine is used for chronic pain, it is generally considered an adjunct to a broader plan that may include rehabilitation, medication review, and psychological or behavioral support.